Literature DB >> 6818133

Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.

R Varon, W J Kleijer, E J Thompson, A d'Azzo.   

Abstract

Reduced activity of beta-glucosidase was shown in the cultured skin fibroblasts of four patients with I-cell disease when the enzyme was tested without the use of detergents. In the presence of taurocholate and triton X100 beta-glucosidase activity was normal. This suggested a deficiency of a beta-glucosidase activating factor in I-cell fibroblasts rather than of the enzyme itself. The deficiency of beta-glucosidase activity was corrected to some extent by mixing cell lysates, and more effectively by cocultivation and fusion of I-cell disease and Gaucher fibroblasts. These results present evidence for the presence of a beta-glucosidase-activating factor in normal and Gaucher fibroblasts. In fibroblasts of patients with I-cell disease this activator is probably deficient, as is the case for most lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818133     DOI: 10.1007/bf00295605

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts.

Authors:  O T Mueller; A Rosenberg
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

2.  Leroy's l-cell disease: markedly increased activity of plasma acid hydrolases.

Authors:  W R Den Tandt; E Lassila; M Philippart
Journal:  J Lab Clin Med       Date:  1974-03

3.  I-cell disease: biochemical studies.

Authors:  J G Leroy; M W Ho; M C MacBrinn; K Zielke; J Jacob; J S O'Brien
Journal:  Pediatr Res       Date:  1972-10       Impact factor: 3.756

4.  Isolation of human fibroblast heterokaryons with two-colour flow sorting (FACS II).

Authors:  J F Jongkind; A Verkerk; H Tanke
Journal:  Exp Cell Res       Date:  1979-05       Impact factor: 3.905

5.  I-cell disease: activities of lysosomal enzymes toward natural and synthetic substrates.

Authors:  D A Wenger; M Sattler; C Clark; C Wharton
Journal:  Life Sci       Date:  1976-08-01       Impact factor: 5.037

6.  Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.

Authors:  S P Peters; P Coyle; C J Coffee; R H Glew
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

7.  Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.

Authors:  M W Ho
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

8.  A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase.

Authors:  P G Pentchev; A E Gal; A D Booth; F Omodeo-Sale; J Fouks; B A Neumeyer; J M Quirk; G Dawson; R O Brady
Journal:  Biochim Biophys Acta       Date:  1980-09-08

9.  Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.

Authors:  H Christomanou
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-10

10.  Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts.

Authors:  A d'Azzo; D J Halley; A Hoogeveen; H Galjaard
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

View more
  1 in total

1.  Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.

Authors:  E Ranieri; B Paton; A Poulos
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.